Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Type: Journal article
Title: CEDIAÒ sirolimus assay compared with HPLC-MS/MS and HPLC-UV in transplant recipient specimens
Other Titles: CEDIAO sirolimus assay compared with HPLC-MS/MS and HPLC-UV in transplant recipient specimens
Author: Westley, I.
Morris, R.
Taylor, P.
Salm, P.
James, M.
Citation: Therapeutic Drug Monitoring, 2005; 27(3):309-314
Publisher: Lippincott Williams & Wilkins
Issue Date: 2005
ISSN: 0163-4356
Statement of
Westley, Ian S; Morris, Raymond G; Taylor, Paul J; Salm, Paul; James, Maree J
Abstract: The role of the therapeutic drug monitoring laboratory in support of immunosuppressant drug therapy is well established, and the introduction of sirolimus (SRL) is a new direction in this field. The lack of an immunoassay for several years has restricted the availability of SRL assay services. The recent availability of a CEDIA SRL assay has the potential to improve this situation. The present communication has compared the CEDIA SRL method with 2 established chromatographic methods, HPLC-UV and HPLC-MS/MS. The CEDIA method, run on a Hitachi 917 analyzer, showed acceptable validation criteria with within-assay precision of 9.1% and 3.3%, and bias of 17.1% and 5.8%, at SRL concentrations of 5.0 microg/L and 20 microg/L, respectively. The corresponding between-run precision values were 11.5% and 3.3% and bias of 7.1% and 2.9% at 5.0 microg/L and 20 microg/L, respectively. The lower limit of quantification was found to be 3.0 microg/L. A series of 96 EDTA whole-blood samples predominantly from renal transplant recipients were assayed by the 3 methods for comparison. It was found that the CEDIA method showed a Deming regression line of CEDIA=1.20xHPLC-MS/MS-0.07 (r=0.934, SEE=.47), with a mean bias of 20.4%. Serial blood samples from 8 patients included in this evaluation showed that the CEDIA method reflected the clinical fluctuations in the chromatographic methods, albeit with the variable bias noted. The CEDIA method on the H917 analyzer is therefore a useful adjunct to SRL dosage individualization in renal transplant recipients.
Keywords: Humans; Sirolimus; Immunosuppressive Agents; Kidney Transplantation; Chromatography, High Pressure Liquid; Ultraviolet Rays; Cross Reactions; Mass Spectrometry
RMID: 0020050442
DOI: 10.1097/01.ftd.0000164394.47520.12
Appears in Collections:Pharmacology publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.